Expression of Pleiotrophin in the Prostate is Androgen Regulated and it Functions as an Autocrine Regulator of Mesenchyme and Cancer Associated Fibroblasts and as a Paracrine Regulator of Epithelia

BACKGROUND. Androgens and paracrine signaling from mesenchyme/stroma regulate development and disease of the prostate, and gene profiling studies of inductive prostate mesenchyme have identified candidate molecules such as pleiotrophin (Ptn). METHODS. Ptn transcripts and protein were localized by in situ and immunohistochemistry and Ptn mRNA was quantitated by Northern blot and qRT-PCR. Ptn function was examined by addition of hPTN protein to rat ventral prostate organ cultures, primary human fetal prostate fibroblasts, prostate cancer associated fibroblasts, and BPH1 epithelia. RESULTS. During development, Ptn transcripts and protein were expressed in ventral mesenchymal pad (VMP) and prostatic mesenchyme. Ptn was localized to mesenchyme surrounding ductal epithelial tips undergoing branching morphogenesis, and was located on the surface of epithelia. hPTN protein stimulated branching morphogenesis and stromal and epithelial proliferation, when added to rat VP cultures, and also stimulated growth of fetal human prostate fibroblasts, prostate cancer associated fibroblasts, and BPH1 epithelia. PTN mRNA was enriched in patient-matched normal prostate fibroblasts versus prostate cancer associated fibroblasts. PTN also showed male enriched expression in fetal human male urethra versus female, and between wt male and ARKO male mice. Transcripts for PTN were upregulated by testosterone in fetal human prostate fibroblasts and organ cultures of female rat VMP. Ptn protein was increased by testosterone in organ cultures of female rat VMP and in rat male urethra compared to female. CONCLUSIONS. Our data suggest that in the prostate Ptn functions as a regulator of both mesenchymal and epithelial proliferation, and that androgens regulate Ptn levels.

[1]  Mustafa Ozen,et al.  Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer , 2009, Clinical Cancer Research.

[2]  G Parmigiani,et al.  Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer , 2008, Oncogene.

[3]  A. Thomson.  Mesenchymal mechanisms in prostate organogenesis. , 2008, Differentiation; research in biological diversity.

[4]  G. Prins,et al.  Molecular signaling pathways that regulate prostate gland development. , 2008, Differentiation; research in biological diversity.

[5]  P. Pérez-Piñera,et al.  Pleiotrophin, A Multifunctional Tumor Promoter Through Induction of Tumor Angiogenesis, Remodeling of the Tumor Microenvironment, and Activation of Stromal Fibroblasts , 2007, Cell cycle.

[6]  K. Boheler,et al.  The Pro-angiogenic Cytokine Pleiotrophin Potentiates Cardiomyocyte Apoptosis through Inhibition of Endogenous AKT/PKB Activity* , 2007, Journal of Biological Chemistry.

[7]  G. Vanpoucke,et al.  Transcriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and disease , 2007, Genome Biology.

[8]  T. Muramatsu,et al.  Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[9]  C. Helgason,et al.  SAGE reveals expression of Wnt signalling pathway members during mouse prostate development. , 2006, Gene expression patterns : GEP.

[10]  R. Sharpe,et al.  Development and function of the adult generation of Leydig cells in mice with Sertoli cell-selective or total ablation of the androgen receptor. , 2005, Endocrinology.

[11]  K. Christman,et al.  Pleiotrophin induces formation of functional neovasculature in vivo. , 2005, Biochemical and biophysical research communications.

[12]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[13]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[14]  J. Lü,et al.  Global analysis of genes differentially expressed in branching and non-branching regions of the mouse embryonic lung. , 2004, Developmental biology.

[15]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[16]  I. Bernard-Pierrot,et al.  Heparin affin regulatory peptide in milk: its involvement in mammary gland homeostasis. , 2004, Biochemical and biophysical research communications.

[17]  Rajvir Dahiya,et al.  Hormonal, cellular, and molecular control of prostatic development. , 2003, Developmental biology.

[18]  S. Hayward,et al.  Role of stroma in carcinogenesis of the prostate. , 2002, Differentiation; research in biological diversity.

[19]  A. Wellstein,et al.  Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma Kinase* , 2002, The Journal of Biological Chemistry.

[20]  G. Ayala,et al.  Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. , 2002, Cancer research.

[21]  T. Sugino,et al.  An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. , 2002, The American journal of pathology.

[22]  O. Grace,et al.  The role of smooth muscle in regulating prostatic induction. , 2002, Development.

[23]  S. Nigam,et al.  Identification of pleiotrophin as a mesenchymal factor involved in ureteric bud branching morphogenesis. , 2001, Development.

[24]  J. Isaacs,et al.  Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. , 2001, Cancer research.

[25]  T. Vogt,et al.  Enhanced Hippocampal Long-Term Potentiation in Mice Lacking Heparin-Binding Growth-Associated Molecule , 2001, Molecular and Cellular Neuroscience.

[26]  D. Wen,et al.  Identification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor Pleiotrophin* , 2001, The Journal of Biological Chemistry.

[27]  J. Clemens,et al.  Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. , 2001, Developmental biology.

[28]  A. Thomson,et al.  Prostatic growth and development are regulated by FGF10. , 1999, Development.

[29]  D. Chopin,et al.  Involvement of heparin affin regulatory peptide in human prostate cancer , 1999, The Prostate.

[30]  J. Sabourin,et al.  Cellular Distribution of the Angiogenic Factor Heparin Affin Regulatory Peptide (HARP) mRNA and Protein in the Human Mammary Gland , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  T. Muramatsu,et al.  Expression of Midkine and Pleiotropin in Ovarian Tumors , 1997, Obstetrics and gynecology.

[32]  S. Donnini,et al.  An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. , 1997, Cancer research.

[33]  A. Wellstein,et al.  Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Shintani,et al.  6B4 Proteoglycan/Phosphacan, an Extracellular Variant of Receptor-like Protein-tyrosine Phosphatase ζ/RPTPβ, Binds Pleiotrophin/Heparin-binding Growth-associated Molecule (HB-GAM)* , 1996, The Journal of Biological Chemistry.

[35]  G. Aumüller,et al.  Instructive induction of prostate growth and differentiation by a defined urogenital sinus mesenchyme , 1995, Microscopy research and technique.

[36]  E. Castrén,et al.  Expression of HB-GAM (heparin-binding growth-associated molecules) in the pathways of developing axonal processes in vivo and neurite outgrowth in vitro induced by HB-GAM. , 1994, Brain research. Developmental brain research.

[37]  D. Carey,et al.  Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). , 1994, The Journal of biological chemistry.

[38]  A. Wellstein,et al.  Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. , 1992, The Journal of biological chemistry.

[39]  J. Vanderhaeghen,et al.  Cellular distribution of the new growth factor Pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues , 1992, Anatomy and Embryology.

[40]  M. Watson,et al.  Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. , 1990, Science.

[41]  L. Chung,et al.  Stromal-epithelial interactions--I. Induction of prostatic phenotype in urothelium of testicular feminized (Tfm/y) mice. , 1981, Journal of steroid biochemistry.

[42]  G. Vanpoucke,et al.  A role for notch signaling in stromal survival and differentiation during prostate development. , 2009, Endocrinology.

[43]  S. Cramer,et al.  A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. , 2005, Endocrinology.

[44]  I. Thesleff,et al.  Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. , 1995, Development.

[45]  L. Zhang,et al.  The isolation and long-term culture of normal human endometrial epithelium and stroma. Expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progesterone challenges. , 1995, Journal of cell science.

[46]  J. Wilson,et al.  Testosterone formation and metabolism during male sexual differentiation in the human embryo. , 1974, The Journal of clinical endocrinology and metabolism.